KMB vs CL
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
KMB · Kimberly-Clark$108.43 ▼ 1.84%
CL · Colgate-Palmolive$96.56 ▼ 2.16%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- KMB +10.5%
- CL +25.3%
Head to head
| Metric | KMB | CL |
|---|---|---|
| Price | $108.43 | $96.56 |
| Change today | ▼ 1.84% | ▼ 2.16% |
| Market cap | $66.54B | $76.76B |
| Return, 3 months | +1.6% | +3.7% |
| Return, year to date | +11.5% | +24.4% |
| Return, 1 year | +9.7% | +24.8% |
| P/E (TTM) | 10.9 | 37.6 |
| P/B | 22.7 | 266.7 |
| P/E percentile vs own 5y | 0th | 85th |
| Dividend yield | 4.70% | 2.17% |
| Revenue growth (YoY, latest qtr) | +0.6% | +4.6% |
| Net profit growth (YoY) | -31.6% | +1.7% |
| Gross margin | 36.8% | 60.6% |
| Operating margin | 15.2% | 19.2% |
| Net margin | 11.8% | 9.6% |
| Return on equity | 129.4% | 358.9% |
| Analyst target vs. price | +11.7% | +7.0% |
| Analyst buy share | 50% | 80% |
| RSI (14) | 56 | 59 |
| 30-day volatility | 32.8% | 28.2% |
| Max drawdown, 1 year | -21.0% | -17.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CL is the largest of the group by market value.
- CL has returned the most over the past year.
- KMB carries the lowest trailing P/E.
- KMB pays the highest dividend yield.
- CL is growing revenue fastest.
- KMB keeps the most profit per dollar of sales.
- CL has been the calmest stock over the last 30 days.